Literature DB >> 12350223

DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation.

Annemie Haelens1, Guy Verrijdt, Leen Callewaert, Valerie Christiaens, Kris Schauwaers, Ben Peeters, Wilfried Rombauts, Frank Claessens.   

Abstract

The androgen receptor has a subset of target DNA sequences, which are not recognized by any other steroid receptors. The androgen selectivity of these sequences was proposed to be the consequence of the ability of the androgen receptor to dimerize on direct repeats of 5'-TGTTCT-3'-like sequences. This is in contrast with the classical non-selective elements consisting of inverted repeats of the 5'-TGTTCT-3' elements separated by three nucleotides and which are recognized by other steroid receptors in addition to the androgen receptor. We demonstrate that while the DNA-binding domain of the oestrogen receptor is unable to dimerize on direct repeats, dimeric binding can be rescued by replacing the second Zn finger and part of the hinge region by the corresponding fragment of the androgen receptor, but not the glucocorticoid receptor. In this study, we investigate the androgen receptor binding to all natural androgen-selective response elements described so far. We show that a 12-amino acid C-terminal extension of the DNA-binding domain is required for high-affinity binding of the androgen receptor to all these elements. For one androgen-specific low-affinity binding site, the flanking sequences do not contribute to the in vitro affinity of the androgen receptor DNA-binding domain. Surprisingly, however, they control the transcriptional activity of the androgen receptor in transient transfection experiments. In conclusion, we give evidence that the alternative DNA-dependent dimerization of the androgen receptor on direct repeats is a general mechanism for androgen specificity in which the second Zn finger and hinge region are involved. In addition, the sequences flanking an androgen-response element can control the activity of the androgen receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12350223      PMCID: PMC1223063          DOI: 10.1042/BJ20020912

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements.

Authors:  C C Nelson; S C Hendy; R J Shukin; H Cheng; N Bruchovsky; B F Koop; P S Rennie
Journal:  Mol Endocrinol       Date:  1999-12

2.  FHL2, a novel tissue-specific coactivator of the androgen receptor.

Authors:  J M Müller; U Isele; E Metzger; A Rempel; M Moser; A Pscherer; T Breyer; C Holubarsch; R Buettner; R Schüle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

3.  Dimerizing the estrogen receptor DNA binding domain enhances binding to estrogen response elements.

Authors:  M A Kuntz; D J Shapiro
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

4.  Characterization of unique DNA-binding and transcriptional-activation functions in the carboxyl-terminal extension of the zinc finger region in the human vitamin D receptor.

Authors:  J C Hsieh; G K Whitfield; A K Oza; H T Dang; J N Price; M A Galligan; P W Jurutka; P D Thompson; C A Haussler; M R Haussler
Journal:  Biochemistry       Date:  1999-12-07       Impact factor: 3.162

Review 5.  Structural determinants of DNA-binding specificity by steroid receptors.

Authors:  J Zilliacus; A P Wright; J Carlstedt-Duke; J A Gustafsson
Journal:  Mol Endocrinol       Date:  1995-04

6.  DNA-binding mechanism of the monomeric orphan nuclear receptor NGFI-B.

Authors:  G Meinke; P B Sigler
Journal:  Nat Struct Biol       Date:  1999-05

7.  Molecular dynamics simulation in solvent of the estrogen receptor protein DNA binding domain in complex with a non-consensus estrogen response element DNA sequence.

Authors:  L F Harris; M R Sullivan; P D Popken-Harris
Journal:  J Biomol Struct Dyn       Date:  1997-12

8.  Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor.

Authors:  H J List; C Lozano; J Lu; M Danielsen; A Wellstein; A T Riegel
Journal:  Exp Cell Res       Date:  1999-08-01       Impact factor: 3.905

9.  Structural features involved in the formation of a complex between the monomeric or the dimeric form of the rev-erb beta DNA-binding domain and its DNA reactive sites.

Authors:  H Terenzi; P M Alzari; M M Zakin
Journal:  Biochemistry       Date:  1998-08-18       Impact factor: 3.162

10.  Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding.

Authors:  M S Lee; S A Kliewer; J Provencal; P E Wright; R M Evans
Journal:  Science       Date:  1993-05-21       Impact factor: 47.728

View more
  13 in total

Review 1.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

2.  A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels.

Authors:  Tamzin M Tanner; Sarah Denayer; Bart Geverts; Nora Van Tilborgh; Stefanie Kerkhofs; Christine Helsen; Lien Spans; Vanessa Dubois; Adriaan B Houtsmuller; Frank Claessens; Annemie Haelens
Journal:  Cell Mol Life Sci       Date:  2010-02-26       Impact factor: 9.261

Review 3.  Androgen receptor and miR-206 regulation in prostate cancer.

Authors:  Fu Y Chua; Brian D Adams
Journal:  Transcription       Date:  2017-06-09

Review 4.  Structural and functional analysis of domains of the progesterone receptor.

Authors:  Krista K Hill; Sarah C Roemer; Mair E A Churchill; Dean P Edwards
Journal:  Mol Cell Endocrinol       Date:  2011-07-22       Impact factor: 4.102

5.  The rules of DNA recognition by the androgen receptor.

Authors:  Sarah Denayer; Christine Helsen; Lieven Thorrez; Annemie Haelens; Frank Claessens
Journal:  Mol Endocrinol       Date:  2010-03-19

6.  Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.

Authors:  Marilena Lanzino; Diego Sisci; Catia Morelli; Cecilia Garofalo; Stefania Catalano; Ivan Casaburi; Claudia Capparelli; Cinzia Giordano; Francesca Giordano; Marcello Maggiolini; Sebastiano Andò
Journal:  Nucleic Acids Res       Date:  2010-04-26       Impact factor: 16.971

7.  Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.

Authors:  Kevin A Link; Sucharitha Balasubramaniam; Ankur Sharma; Clay E S Comstock; Sonia Godoy-Tundidor; Nathan Powers; Khanh H Cao; Annemie Haelens; Frank Claessens; Monica P Revelo; Karen E Knudsen
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

8.  A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists.

Authors:  Toine F H Bovee; Richard J R Helsdingen; Astrid R M Hamers; Majorie B M van Duursen; Michel W F Nielen; Ron L A P Hoogenboom
Journal:  Anal Bioanal Chem       Date:  2007-09-12       Impact factor: 4.142

9.  Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model.

Authors:  Kris Schauwaers; Karel De Gendt; Philippa T K Saunders; Nina Atanassova; Annemie Haelens; Leen Callewaert; Udo Moehren; Johannes V Swinnen; Guido Verhoeven; Guy Verrijdt; Frank Claessens
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-12       Impact factor: 11.205

Review 10.  Diverse roles of androgen receptor (AR) domains in AR-mediated signaling.

Authors:  Frank Claessens; Sarah Denayer; Nora Van Tilborgh; Stefanie Kerkhofs; Christine Helsen; Annemie Haelens
Journal:  Nucl Recept Signal       Date:  2008-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.